Zacks: On Track Innovations Ltd (OTIV) Given $2.50 Average Price Target by Brokerages

Share on StockTwits

On Track Innovations Ltd (NASDAQ:OTIV) has received a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy rating.

Analysts have set a 12 month consensus target price of $2.50 for the company and are expecting that the company will post ($0.01) earnings per share for the current quarter, according to Zacks. Zacks has also assigned On Track Innovations an industry rank of 82 out of 255 based on the ratings given to its competitors.

A hedge fund recently bought a new stake in On Track Innovations stock. Essex Investment Management Co. LLC purchased a new stake in shares of On Track Innovations Ltd (NASDAQ:OTIV) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 183,024 shares of the technology company’s stock, valued at approximately $214,000. Essex Investment Management Co. LLC owned approximately 0.44% of On Track Innovations as of its most recent SEC filing. Institutional investors own 3.14% of the company’s stock.

Shares of OTIV traded down $0.02 during mid-day trading on Tuesday, hitting $0.91. 58,301 shares of the company’s stock traded hands, compared to its average volume of 51,304. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.28 and a current ratio of 1.54. On Track Innovations has a 1 year low of $0.86 and a 1 year high of $2.94. The stock has a market capitalization of $37.58 million, a PE ratio of -22.75 and a beta of 1.56.

On Track Innovations (NASDAQ:OTIV) last posted its earnings results on Wednesday, August 8th. The technology company reported ($0.01) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.01). On Track Innovations had a negative return on equity of 12.27% and a negative net margin of 1.87%. The firm had revenue of $6.15 million for the quarter, compared to analysts’ expectations of $6.20 million. Research analysts forecast that On Track Innovations will post -0.02 EPS for the current fiscal year.

About On Track Innovations

On Track Innovations Ltd. designs, develops, and markets cashless payment solutions worldwide. It operates through Retail and Mass Transit Ticketing; and Petroleum segments. The company offers OTI UNO, a single interface and contactless reader that support the major card associations' applications, as well as wallets such as Apple Pay, Google Pay, and Samsung Pay; OTI TRIO, a near-field communication and contactless reader, which offers three-in-one cashless payment card options comprising magnetic stripe (swipe), contact (chip), and contactless (tap); and OTI Interno, an original equipment manufacturer reader module with integrated antenna used for integration into mass transit validators and terminals.

Featured Story: What are trading strategies for the 52-week high/low?

Get a free copy of the Zacks research report on On Track Innovations (OTIV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for On Track Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for On Track Innovations and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Vanguard High Dividend Yield ETF  Shares Bought by Westside Investment Management Inc.
Vanguard High Dividend Yield ETF Shares Bought by Westside Investment Management Inc.
Westside Investment Management Inc. Cuts Stake in FireEye Inc
Westside Investment Management Inc. Cuts Stake in FireEye Inc
Ovid Therapeutics  Upgraded by Zacks Investment Research to “Buy”
Ovid Therapeutics Upgraded by Zacks Investment Research to “Buy”
IQIYI Inc  Shares Bought by Westside Investment Management Inc.
IQIYI Inc Shares Bought by Westside Investment Management Inc.
Nantkwest  Rating Reiterated by Jefferies Financial Group
Nantkwest Rating Reiterated by Jefferies Financial Group
Oppenheimer Reiterates Hold Rating for Gilead Sciences
Oppenheimer Reiterates Hold Rating for Gilead Sciences


© 2006-2018 Ticker Report